首页> 外文期刊>Medicine. >Intraoperative portal vein insulin assay combined with occlusion of the pancreas for complex pancreatogenous hypoglycemia: Two cases report
【24h】

Intraoperative portal vein insulin assay combined with occlusion of the pancreas for complex pancreatogenous hypoglycemia: Two cases report

机译:术中门静脉胰岛素测定结合胰腺闭塞治疗复杂性胰腺源性低血糖2例

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Intraoperative localization and confirmation of complete resection of the hypersecreting tissue are the 2 main challenges in the management of pancreatogenous hypoglycemia. Here, we report our experience with intraoperative portal vein insulin assay combined with occlusion of the pancreas in the management of pancreatogenous hypoglycemia. Clinical courses of 2 patients with biochemical evidence of a pancreatogenous hypoglycemia were studied. The preoperative diagnosis was multiple endocrine neoplasia 1 (MEN-1) and nesidioblastosis, respectively. Rapid intraoperative portal vein insulin assay combined with occlusion of the pancreas was used to localize and confirm complete excision of the hypersecreting tissue. Hypoglycemia was successfully treated in both the patients. In the MEN-1 patient, 2 small tumors in the head of pancreas were not resected, as they were deemed noninsulin secreting by intraoperative portal vein insulin assay, thus avoiding a total pancreatectomy. In the patient with nesidioblastosis, using intraoperative portal vein insulin assay combined with occlusion of the pancreas, an appropriate amount of pancreatic tissue was resected thereby avoiding recurrence and diabetes. This technique may be of particular value in patients with complex conditions such as MEN-1 and nesidioblastosis, to localize and achieve complete resection of hypersecreting pancreatic tissue.
机译:术中定位和完全切除高分泌组织的确诊是胰腺源性低血糖治疗的两个主要挑战。在这里,我们报告我们的术中门静脉胰岛素测定结合胰腺阻塞在胰腺源性低血糖治疗中的经验。研究了2名有胰腺生源性低血糖的生化证据的患者的临床病程。术前诊断分别为多发性内分泌肿瘤1(MEN-1)和成纤维细胞增生。术中快速术中门静脉胰岛素测定结合胰腺闭塞被用于定位并确认过度分泌组织的完全切除。两名患者均成功治疗了低血糖症。在MEN-1患者中,未切除胰头中的2个小肿瘤,因为在术中门静脉胰岛素测定法中它们被认为是非胰岛素分泌的,因此避免了全胰腺切除术。对于具有成纤维细胞病的患者,通过术中门静脉胰岛素测定结合胰腺阻塞,切除了适量的胰腺组织,从而避免了复发和糖尿病。这项技术在诸如MEN-1和奈瑟氏成纤维细胞病等复杂疾病患者中,对于定位并完全切除高分泌胰腺组织的患者可能具有特殊价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号